.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Citi
Cantor Fitzgerald
Cerilliant
Baxter
Healthtrust
Queensland Health
US Army
Federal Trade Commission
Fish and Richardson

Generated: September 24, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Which drugs does patent 9,198,871 protect, and when does it expire?


Patent ► Subscribe protects CREON and is included in one NDA.

This patent has forty-two patent family members in twenty-two countries.

Summary for Patent: ► Subscribe

Title:Delayed release pancreatin compositions
Abstract: An enteric-coated oral dosage form comprising an acid labile active pharmaceutical ingredient where the composition is substantially free of monomeric phthalic acid esters and synthetic oils is described herein. Also provided are methods for making and using the enteric-coated oral dosage form. The disclosed pharmaceutical compositions comprise an enteric coating which includes at least one plasticizer, at least one film-forming agent and optionally at least one anti-sticking agent.
Inventor(s): Shlieout; George (Sehnde, DE), Koelln; Claus-Juergen (Neustadt, DE), Sczesny; Frithjof (Hannover, DE), Onken; Jens (Barsinghausen, DE), Koerner; Andreas (Springe, DE)
Assignee: Abbott Products GmbH (Hanover, DE)
Application Number:11/464,754
Patent Claim Types:
see list of patent claims
Compound; Process; Use; Dosage form; Composition; Formulation;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Abbvie
CREON
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL020725-002Apr 30, 2009RXYesNo► Subscribe► SubscribeY TREATMENT OF EXOCRINE PANCREATIC INSUFFICIENCY
Abbvie
CREON
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL020725-004Jul 12, 2011RXYesNo► Subscribe► SubscribeY TREATMENT OF EXOCRINE PANCREATIC INSUFFICIENCY
Abbvie
CREON
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL020725-001Apr 30, 2009RXYesNo► Subscribe► SubscribeY TREATMENT OF EXOCRINE PANCREATIC INSUFFICIENCY
Abbvie
CREON
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL020725-005Mar 14, 2013RXYesNo► Subscribe► SubscribeY TREATMENT OF EXOCRINE PANCREATIC INSUFFICIENCY
Abbvie
CREON
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL020725-003Apr 30, 2009RXYesYes► Subscribe► SubscribeY TREATMENT OF EXOCRINE PANCREATIC INSUFFICIENCY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: ► Subscribe

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Mexico2008001558► Subscribe
Mexico2008001557► Subscribe
South Korea20080034515► Subscribe
European Patent Office1931316► Subscribe
European Patent Office1931317► Subscribe
Spain2320174► Subscribe
Spain2341284► Subscribe
Hong Kong1119559► Subscribe
Hong Kong1121037► Subscribe
CroatiaP20100269► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
AstraZeneca
Farmers Insurance
Teva
Deloitte
McKesson
Johnson and Johnson
Cantor Fitzgerald
Daiichi Sankyo
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot